Quarterly Consolidated Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7720512

Concept As at
2018-05-31
2017-06-01 to
2018-05-31
2016-06-01 to
2017-05-31
As at
2017-05-31
As at
2016-05-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
40,893,000,000 JPY
44,957,000,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-88,000,000 JPY
-98,000,000 JPY
Income taxes paid
-8,300,000,000 JPY
-8,680,000,000 JPY
Net cash provided by (used in) operating activities
32,586,000,000 JPY
36,938,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-29,451,000,000 JPY
-28,667,000,000 JPY
Proceeds from sale of property, plant and equipment
186,000,000 JPY
538,000,000 JPY
Other, net
-754,000,000 JPY
-366,000,000 JPY
Net cash provided by (used in) investing activities
-30,458,000,000 JPY
-28,404,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-4,486,000,000 JPY
-4,951,000,000 JPY
Purchase of treasury shares
JPY
0 JPY
Dividends paid
-1,781,000,000 JPY
-1,385,000,000 JPY
Net cash provided by (used in) financing activities
-8,188,000,000 JPY
-8,088,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-6,060,000,000 JPY
445,000,000 JPY
Cash and cash equivalents
21,668,000,000 JPY
27,728,000,000 JPY
27,282,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.